41 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
included in the accompanying Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
with the limitations set forth in this Section 1 on the amount of Placement Shares issued and sold under this Agreement shall be the sole responsibility … responsibility against such losses and risks and in such amounts as are prudent and customary for companies of similar size as the Company in the businesses
424B5
mz3q5j
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
k9btwrbryswtv
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-1.1
33mue
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
3qisa
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
20bn43hr8
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
sx39fcg3 lii
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
bljud57 s4joxwt5
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
geupcg4 ev628gafyeve
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
zyx72mp
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
egwiaq
3 Mar 20
Prospectus supplement for primary offering
5:13pm